Pharmaceutical Raw Materials Respiratory System Drugs Roflumilast for COPD 162401-32-3

• Post Date:

  Oct 09,2017

• Expiry Date:

  Oct 09,2018

• Detailed Description:

  Payment Method: Western Union, MoneyGram,Bank Transfer,Bitcoi
  Pharmaceutical Raw Materials Respiratory System Drugs Roflumilast for COPD 162401-32-3
  
  
  
  Basic Info.
  
  Roflumilast
  Synonyms: ROFLUMILAST;3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide;B 9302-107;BY 217;BYK 20869;Daxas;Roflumilast / 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide;3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide
  CAS: 162401-32-3
  MF: C17H14Cl2F2N2O3
  MW: 403.21
  MP: 158°C
  storage temp. Refrigerator
  Chemical Properties Crystallin Solid
  Usage Selective phosphodiesterase 4(PDE4) inhibitor. Antiasthmatic; in treatment of chronic obstructive pulmonary disease
  Purity: 99%
  Usage: API
  Package: 1KG foil bag; 25Kg drum
  
  
  Description:
  
  Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor. Due to its selective inhibition of the PDE4 isoenzyme in lung cells, roflumilast is indicated for the management of chronic obstrtuctive pulmonary disease (COPD) exacerbations. Treatment with Roflumilast is associated with an increase in psychiatric adverse reactions, including suicide and suicidal attempts.

• Company:

  Guangzhou Kafen Biotech Co.,Ltd     [ China ]        

• Contact:

  Laura

• Tel:

  +86-020-31121676

• Fax:

  +8613332873040

• Email:

  laura@rawroids.com